Neuronetrix Announces Clinical Trial Collaboration With Premier Research Institutes for a New Alzheimer's Disease Diagnostic Test
LOUISVILLE, KY -- Researchers at the University of Kentucky Sanders-Brown Center on Aging and Duke University Medical Center have signed a contract with Neuronetrix, Inc. to kick-start a multi-center clinical trial to test brainwaves as useful cognitive biomarkers for Alzheimer's disease (AD).
Information about Neuronetrix is available at http://www.neuronetrix.com or by contacting K.C. Fadem at kfadem@neuronetrix.com or (502) 561-9040.
Read More: www.marketwire.com/press-release/Neuronetrix-Announces-Clinical-Trial-Collaboration-With-Premier-Research-Institutes-1285105.htm
No comments:
Post a Comment